Table 2.
Analyses | Number of Part D Drugs | Number of Chronic Conditions | Groups | Number Eligible | Number Eligible Weighted | Proportion Eligible (%) |
---|---|---|---|---|---|---|
Main Analysis | ≥ 5 | ≥ 3 | Whites | 218 | 2,213,487 | 3.53 |
Blacks | 39 | 249,685 | 3.52 | |||
Hispanics | 29 | 133,588 | 3.42 | |||
Sensitivity Analysis 1 | ≥ 5 | ≥ 2 | Whites | 203 | 1,970,807 | 3.14 |
Blacks | 33 | 198,880 | 2.80 | |||
Hispanics | 26 | 122,380 | 3.14 | |||
Sensitivity Analysis 2 | ≥ 5 | ≥ 5 | Whites | 129 | 1,280,298 | 2.04 |
Blacks | 17 | 117,679 | 1.66 | |||
Hispanics | 18 | 95,640 | 2.45 | |||
Sensitivity Analysis 3 | ≥ 2 | ≥ 3 | Whites | 209 | 2,056,866 | 3.28 |
Blacks | 33 | 198,880 | 2.80 | |||
Hispanics | 26 | 122,380 | 3.14 | |||
Sensitivity Analysis 4 | ≥ 2 | ≥ 2 | Whites | 231 | 2,382,206 | 3.80 |
Blacks | 39 | 249,685 | 3.52 | |||
Hispanics | 29 | 133,588 | 3.42 | |||
Sensitivity Analysis 5 | ≥ 2 | ≥ 5 | Whites | 131 | 1,315,030 | 2.10 |
Blacks | 17 | 117,679 | 1.66 | |||
Hispanics | 18 | 95,640 | 2.45 | |||
Sensitivity Analysis 6 | ≥ 15 | ≥ 3 | Whites | 83 | 762,634 | 1.22 |
Blacks | 6 | 51,811 | 0.73 | |||
Hispanics | 11 | 42,941 | 1.10 | |||
Sensitivity Analysis 7 | ≥ 15 | ≥ 2 | Whites | 86 | 838,846 | 1.34 |
Blacks | 8 | 58,165 | 0.82 | |||
Hispanics | 13 | 50,250 | 1.29 | |||
Sensitivity Analysis 8 | ≥ 15 | ≥ 5 | Whites | 62 | 566,763 | 0.90 |
Blacks | 5 | 49,514 | 0.70 | |||
Hispanics | 9 | 34,934 | 0.90 |
Note: Whites: non-Hispanic whites; Blacks: non-Hispanic blacks; total Part D drugs costs ≥ 4,000 in 2006 dollar for all analyses.
P > 0.05 when comparing Whites to Blacks and Whites to Hispanics based on all analyses.